Acrivon Therapeutics (ACRV) Stock Chart & Stock Price History $5.39 -0.22 (-3.92%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$4.64 -0.75 (-13.90%) As of 08:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acrivon Therapeutics Stock Price Performance 5 Day Performance+0.56%1 Month Performance+1.51%3 Month Performance-12.92%6 Month Performance-25.76%Year-To-Date Performance-10.47%1 Year Performance-14.85% Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ACRV Stock Chart for Wednesday, March, 26, 2025 ACRV Chart by TradingViewRemove Ads Acrivon Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/25/2025$5.61$5.39-3.92%$5.62$5.3545,414 shs$167.82 million03/24/2025$5.36$5.61+4.66%$5.65$5.2539,756 shs$174.67 million03/21/2025$5.14$5.36+4.28%$5.40$5.0064,738 shs$166.89 million03/20/2025$5.46$5.14-5.86%$5.52$5.1414,471 shs$160.04 million03/19/2025$5.36$5.46+1.87%$5.62$5.2021,762 shs$170.00 million03/18/2025$5.50$5.36-2.55%$5.42$5.2915,296 shs$166.89 million03/17/2025$5.44$5.50+1.10%$5.57$5.3216,522 shs$171.25 million03/14/2025$5.07$5.44+7.30%$5.46$5.1917,905 shs$169.38 million03/13/2025$5.33$5.07-4.88%$5.36$5.0713,743 shs$157.86 million03/12/2025$5.45$5.33-2.20%$5.39$5.1618,510 shs$165.96 million Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/11/2025$5.29$5.45+3.02%$5.54$5.2118,444 shs$169.69 million03/10/2025$5.54$5.29-4.51%$5.45$5.1823,839 shs$164.71 million03/07/2025$5.51$5.54+0.54%$5.58$5.3111,979 shs$172.49 million03/06/2025$5.58$5.51-1.25%$5.68$5.2919,379 shs$171.56 million03/05/2025$5.36$5.58+4.10%$5.75$5.3331,416 shs$173.74 million03/04/2025$5.14$5.36+4.28%$5.55$5.1455,202 shs$166.89 million03/03/2025$5.31$5.14-3.20%$5.54$5.0732,486 shs$160.04 million02/28/2025$5.34$5.31-0.56%$5.59$5.2521,356 shs$165.33 million02/27/2025$5.31$5.34+0.56%$5.68$5.2720,271 shs$166.27 million02/26/2025$5.53$5.31-3.98%$5.65$5.3117,599 shs$172.18 million02/25/2025$5.38$5.53+2.79%$5.68$5.3141,190 shs$172.20 million Related Companies ArriVent BioPharma Stock Chart Organogenesis Stock Chart CureVac Stock Chart GH Research Stock Chart Nuvation Bio Stock Chart CorMedix Stock Chart Immunome Stock Chart Arbutus Biopharma Stock Chart Bicycle Therapeutics Stock Chart Dianthus Therapeutics Stock Chart Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRV) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACRV Stock Free ACRV Stock Alerts